The National Committee on Biosafety of the Philippines (NCBP) and the Advanced Science and Technology Institute (ASTI) held ...

Miraculin is a naturally occurring glycoprotein derived from the miracle fruit (Synsepalum dulcificum) that has garnered significant scientific interest due to its unique ability to modify taste ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial ...

Colossal Biosciences, the Dallas-based biotechnology company known for its bold mission to resurrect extinct species such as ...

Award recognizes the groundbreaking science of Dupixent and its transformational impact on multiple rare and common allergic and atopic conditions ...

UD chemical engineer wins the AIChE Langer Prize for efforts to harness biology to manage plastic waste sustainably ...

Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...

Galecto, Inc. ( ($GLTO) ) has released its Q3 earnings. Here is a breakdown of the information Galecto, Inc. presented to its investors. Galecto, ...

NovaBridge subsidiary Visara assigned its exclusive license to Everest Medicines to accelerate the development of potential best-in-class therapy for wet AMD, VIS-101, leveraging Everest Medicines' st ...

Still, the recently released 2025-30 Arizona Bioscience Roadmap, as well as several academic, community and local government ...

Applications Across Industries: Membrane-based solutions in water and wastewater treatment, desalination, energy, ...

Growing consensus is emerging that artificial intelligence (AI) may assist biotechnology and life sciences companies to draft patents that satisfy written description and enablement requirements.